Inventiva Announces Results of Combined Shareholders' Meeting.

viernes, 28 de noviembre de 2025, 2:36 am ET1 min de lectura
IVA--

Inventiva, a clinical-stage biopharmaceutical company, announced the results of its Combined Shareholders' Meeting. All resolutions were adopted except for the 5th resolution, which was not recommended by the Board of Directors. The meeting was held on November 27, 2025, at Hôtel Villa M in Paris.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios